{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:30:51Z","timestamp":1791588651633,"version":"4.3.4"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2010,6,29]],"date-time":"2010-06-29T00:00:00Z","timestamp":1277769600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1038\/nrgastro.2010.97","type":"journal-article","created":{"date-parts":[[2010,6,29]],"date-time":"2010-06-29T05:49:54Z","timestamp":1277790594000},"page":"425-436","source":"Crossref","is-referenced-by-count":516,"title":["Evolving challenges in hepatic fibrosis"],"prefix":"10.1038","volume":"7","author":[{"given":"Scott L.","family":"Friedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,6,29]]},"reference":[{"key":"BFnrgastro201097_CR1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/ncpgasthep0055","volume":"1","author":"SL Friedman","year":"2004","unstructured":"Friedman, S. L. Mechanisms of hepatic fibrosis and therapeutic implications. Nat. Clin. Pract. Gastroenterol. Hepatol. 1, 98\u2013105 (2004).","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"BFnrgastro201097_CR2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.23561","volume":"51","author":"AE Mitchell","year":"2010","unstructured":"Mitchell, A. E., Colvin, H. M. & Palmer Beasley, R. Institute of Medicine recommendations for the prevention and control of hepatitis B and C. Hepatology 51, 729\u2013733 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.gastro.2009.09.067","volume":"138","author":"GL Davis","year":"2010","unstructured":"Davis, G. L., Alter, M. J., El-Serag, H., Poynard, T. & Jennings, L. W. Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression. Gastroenterology 138, 513\u2013521, 521 e1\u20136 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cld.2008.07.007","volume":"12","author":"YS Lim","year":"2008","unstructured":"Lim, Y. S. & Kim, W. R. The global impact of hepatic fibrosis and end-stage liver disease. Clin. Liver Dis. 12, 733\u2013746 (2008).","journal-title":"Clin. Liver Dis."},{"key":"BFnrgastro201097_CR5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/MOG.0b013e3283294a18","volume":"25","author":"O Cheung","year":"2009","unstructured":"Cheung, O. & Sanyal, A. J. Recent advances in nonalcoholic fatty liver disease. Curr. Opin. Gastroenterol. 25, 230\u2013237 (2009).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"BFnrgastro201097_CR6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cld.2007.02.006","volume":"11","author":"E Bugianesi","year":"2007","unstructured":"Bugianesi, E. Non-alcoholic steatohepatitis and cancer. Clin. Liver Dis. 11, 191\u2013207 (2007).","journal-title":"Clin. Liver Dis."},{"key":"BFnrgastro201097_CR7","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/MEG.0b013e3282748ef2","volume":"19","author":"H Hashizume","year":"2007","unstructured":"Hashizume, H. et al. Primary liver cancers with nonalcoholic steatohepatitis. Eur. J. Gastroenterol. Hepatol. 19, 827\u2013834 (2007).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201097_CR8","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal, A. et al. Cancer statistics, 2009. CA Cancer J. Clin. 59, 225\u2013249 (2009).","journal-title":"CA Cancer J. Clin."},{"key":"BFnrgastro201097_CR9","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman, S. L. Mechanisms of hepatic fibrogenesis. Gastroenterology 134, 1655\u20131669 (2008).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR10","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(08)60383-9","volume":"371","author":"D Schuppan","year":"2008","unstructured":"Schuppan, D. & Afdhal, N. H. Liver cirrhosis. Lancet 371, 838\u2013851 (2008).","journal-title":"Lancet"},{"key":"BFnrgastro201097_CR11","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MOG.0b013e3283279668","volume":"25","author":"J Jiao","year":"2009","unstructured":"Jiao, J., Friedman, S. L. & Aloman, C. Hepatic fibrosis. Curr. Opin. Gastroenterol. 25, 223\u2013229 (2009).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"BFnrgastro201097_CR12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-1536-2-4","volume":"2","author":"M Parola","year":"2009","unstructured":"Parola, M. & Pinzani, M. Hepatic wound repair. Fibrogenesis Tissue Repair 2, 4 (2009).","journal-title":"Fibrogenesis Tissue Repair"},{"key":"BFnrgastro201097_CR13","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1042\/CS20060242","volume":"112","author":"NC Henderson","year":"2007","unstructured":"Henderson, N. C. & Iredale, J. P. Liver fibrosis: cellular mechanisms of progression and resolution. Clin. Sci. (Lond.) 112, 265\u2013280 (2007).","journal-title":"Clin. Sci. (Lond.)"},{"key":"BFnrgastro201097_CR14","doi-asserted-by":"crossref","first-page":"e6657","DOI":"10.1371\/journal.pone.0006657","volume":"4","author":"RM Baertschiger","year":"2009","unstructured":"Baertschiger, R. M. et al. Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver. PLOS ONE 4, e6657 (2009).","journal-title":"PLOS ONE"},{"key":"BFnrgastro201097_CR15","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1182\/blood-2007-07-101261","volume":"111","author":"E Miyata","year":"2008","unstructured":"Miyata, E. et al. Hematopoietic origin of hepatic stellate cells in the adult liver. Blood 111, 2427\u20132435 (2008).","journal-title":"Blood"},{"key":"BFnrgastro201097_CR16","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2006.01.036","volume":"130","author":"FP Russo","year":"2006","unstructured":"Russo, F. P. et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology 130, 1807\u20131821 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR17","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1053\/j.gastro.2004.02.025","volume":"126","author":"SJ Forbes","year":"2004","unstructured":"Forbes, S. J. et al. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126, 955\u2013963 (2004).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR18","doi-asserted-by":"crossref","first-page":"G974","DOI":"10.1152\/ajpgi.00055.2009","volume":"297","author":"T Fujimiya","year":"2009","unstructured":"Fujimiya, T. et al. Pathological roles of bone-marrow-derived stellate cells in a mouse model of alcohol-induced fatty liver. Am. J. Physiol. Gastrointest. Liver Physiol. 297, G974\u2013G980 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro201097_CR19","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1378\/chest.09-0510","volume":"136","author":"RM Strieter","year":"2009","unstructured":"Strieter, R. M. & Mehrad, B. New mechanisms of pulmonary fibrosis. Chest 136, 1364\u20131370 (2009).","journal-title":"Chest"},{"key":"BFnrgastro201097_CR20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrneph.2009.74","volume":"5","author":"MT Grande","year":"2009","unstructured":"Grande, M. T. & Lopez-Novoa, J. M. Fibroblast activation and myofibroblast generation in obstructive nephropathy. Nat. Rev. Nephrol. 5, 319\u2013328 (2009).","journal-title":"Nat. Rev. Nephrol."},{"key":"BFnrgastro201097_CR21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jhep.2006.04.014","volume":"45","author":"T Kisseleva","year":"2006","unstructured":"Kisseleva, T. et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J. Hepatol. 45, 429\u2013438 (2006).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201097_CR22","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1053\/j.gastro.2009.07.006","volume":"137","author":"R Higashiyama","year":"2009","unstructured":"Higashiyama, R. et al. Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology 137, 1459\u20131466 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR23","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI200320530","volume":"112","author":"R Kalluri","year":"2003","unstructured":"Kalluri, R. & Neilson, E. G. Epithelial-mesenchymal transition and its implications for fibrosis. J. Clin. Invest. 112, 1776\u20131784 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201097_CR24","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2353\/ajpath.2008.080433","volume":"173","author":"SL Lin","year":"2008","unstructured":"Lin, S. L., Kisseleva, T., Brenner, D. A. & Duffield, J. S. Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am. J. Pathol. 173, 1617\u20131627 (2008).","journal-title":"Am. J. Pathol."},{"key":"BFnrgastro201097_CR25","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2353\/ajpath.2010.090517","volume":"176","author":"BD Humphreys","year":"2010","unstructured":"Humphreys, B. D. et al. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am. J. Pathol. 176, 85\u201397 (2010).","journal-title":"Am. J. Pathol."},{"key":"BFnrgastro201097_CR26","doi-asserted-by":"crossref","first-page":"23337","DOI":"10.1074\/jbc.M700194200","volume":"282","author":"M Zeisberg","year":"2007","unstructured":"Zeisberg, M. et al. Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition. J. Biol. Chem. 282, 23337\u201323347 (2007).","journal-title":"J. Biol. Chem."},{"key":"BFnrgastro201097_CR27","first-page":"3331","volume":"118","author":"A Omenetti","year":"2008","unstructured":"Omenetti, A. et al. Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J. Clin. Invest. 118, 3331\u20133342 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201097_CR28","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.23019","volume":"50","author":"A Omenetti","year":"2009","unstructured":"Omenetti, A. et al. Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production. Hepatology 50, 518\u2013527 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR29","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/hep.23196","volume":"50","author":"SS Choi","year":"2009","unstructured":"Choi, S. S. & Diehl, A. M. Epithelial-to-mesenchymal transitions in the liver. Hepatology 50, 2007\u20132013 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR30","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/hep.23368","volume":"51","author":"K Taura","year":"2010","unstructured":"Taura, K. et al. Hepatocytes do not undergo epithelial-mesenchymal transition in liver fibrosis in mice. Hepatology 51, 1027\u20131036 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR31","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.23529","volume":"51","author":"RG Wells","year":"2010","unstructured":"Wells, R. G. The epithelial-to-mesenchymal transition in liver fibrosis: here today, gone tomorrow? Hepatology 51, 737\u2013740 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR32","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bbrc.2006.11.029","volume":"352","author":"C Kordes","year":"2007","unstructured":"Kordes, C. et al. CD133+ hepatic stellate cells are progenitor cells. Biochem. Biophys. Res. Commun. 352, 410\u2013417 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrgastro201097_CR33","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/hep.23184","volume":"50","author":"I Sawitza","year":"2009","unstructured":"Sawitza, I., Kordes, C., Reister, S. & Haussinger, D. The niche of stellate cells within rat liver. Hepatology 50, 1617\u20131624 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR34","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.cld.2008.07.014","volume":"12","author":"T Roskams","year":"2008","unstructured":"Roskams, T. Relationships among stellate cell activation, progenitor cells, and hepatic regeneration. Clin. Liver Dis. 12, 853\u2013860 (2008).","journal-title":"Clin. Liver Dis."},{"key":"BFnrgastro201097_CR35","first-page":"1858","volume":"119","author":"E Seki","year":"2009","unstructured":"Seki, E. et al. CCR1 and CCR5 promote hepatic fibrosis in mice. J. Clin. Invest. 119, 1858\u20131870 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201097_CR36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/hep.22952","volume":"50","author":"E Seki","year":"2009","unstructured":"Seki, E. et al. CCR2 promotes hepatic fibrosis in mice. Hepatology 50, 185\u2013197 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR37","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1055\/s-2001-17554","volume":"21","author":"M Pinzani","year":"2001","unstructured":"Pinzani, M. & Marra, F. Cytokine receptors and signaling in hepatic stellate cells. Semin. Liver Dis. 21, 397\u2013416 (2001).","journal-title":"Semin. Liver Dis."},{"key":"BFnrgastro201097_CR38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.gastro.2009.03.053","volume":"137","author":"HE Wasmuth","year":"2009","unstructured":"Wasmuth, H. E. et al. Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans. Gastroenterology 137, 309\u2013319, 319 e1\u20133 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR39","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hep.23046","volume":"50","author":"F Marra","year":"2009","unstructured":"Marra, F. & Bertolani, C. Adipokines in liver diseases. Hepatology 50, 957\u2013969 (2009).","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"BFnrgastro201097_CR40","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1440-1746.2007.04961.x","volume":"22","author":"K Ikejima","year":"2007","unstructured":"Ikejima, K., Okumura, K., Kon, K., Takei, Y. & Sato, N. Role of adipocytokines in hepatic fibrogenesis. J. Gastroenterol. Hepatol. 22 (Suppl. 1), S87\u2013S92 (2007).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201097_CR41","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0002-9440(10)62476-5","volume":"166","author":"X Ding","year":"2005","unstructured":"Ding, X. et al. The roles of leptin and adiponectin: a novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am. J. Pathol. 166, 1655\u20131669 (2005).","journal-title":"Am. J. Pathol."},{"key":"BFnrgastro201097_CR42","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1017\/S146239940800063X","volume":"10","author":"MR Ebrahimkhani","year":"2008","unstructured":"Ebrahimkhani, M. R., Elsharkawy, A. M. & Mann, D. A. Wound healing and local neuroendocrine regulation in the injured liver. Expert Rev. Mol. Med. 10, e11 (2008).","journal-title":"Expert Rev. Mol. Med."},{"key":"BFnrgastro201097_CR43","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nm1421","volume":"12","author":"F Teixeira-Clerc","year":"2006","unstructured":"Teixeira-Clerc, F. et al. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat. Med. 12, 671\u2013676 (2006).","journal-title":"Nat. Med."},{"key":"BFnrgastro201097_CR44","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1124\/jpet.107.131896","volume":"324","author":"J Munoz-Luque","year":"2008","unstructured":"Munoz-Luque, J. et al. Regression of fibrosis after chronic stimulation of cannabinoid CB2 receptor in cirrhotic rats. J. Pharmacol. Exp. Ther. 324, 475\u2013483 (2008).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrgastro201097_CR45","doi-asserted-by":"crossref","first-page":"e5844","DOI":"10.1371\/journal.pone.0005844","volume":"4","author":"V Deveaux","year":"2009","unstructured":"Deveaux, V. et al. Cannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosis. PLoS ONE 4, e5844 (2009).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201097_CR46","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1126\/science.1137603","volume":"315","author":"MA Passino","year":"2007","unstructured":"Passino, M. A., Adams, R. A., Sikorski, S. L. & Akassoglou, K. Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR. Science 315, 1853\u20131856 (2007).","journal-title":"Science"},{"key":"BFnrgastro201097_CR47","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/hep.22701","volume":"49","author":"TJ Kendall","year":"2009","unstructured":"Kendall, T. J. et al. p75 Neurotrophin receptor signaling regulates hepatic myofibroblast proliferation and apoptosis in recovery from rodent liver fibrosis. Hepatology 49, 901\u2013910 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR48","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jhep.2008.12.011","volume":"50","author":"M Fernandez","year":"2009","unstructured":"Fernandez, M. et al. Angiogenesis in liver disease. J. Hepatol. 50, 604\u2013620 (2009).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201097_CR49","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1755-1536-1-5","volume":"1","author":"E Novo","year":"2008","unstructured":"Novo, E. & Parola, M. Redox mechanisms in hepatic chronic wound healing and fibrogenesis. Fibrogenesis Tissue Repair 1, 5 (2008).","journal-title":"Fibrogenesis Tissue Repair"},{"key":"BFnrgastro201097_CR50","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.abb.2007.04.016","volume":"462","author":"S De Minicis","year":"2007","unstructured":"De Minicis, S. & Brenner, D. A. NOX in liver fibrosis. Arch. Biochem. Biophys. 462, 266\u2013272 (2007).","journal-title":"Arch. Biochem. Biophys."},{"key":"BFnrgastro201097_CR51","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/hep.21093","volume":"43","author":"SS Zhan","year":"2006","unstructured":"Zhan, S. S. et al. Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo. Hepatology 43, 435\u2013443 (2006).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR52","doi-asserted-by":"crossref","first-page":"G726","DOI":"10.1152\/ajpgi.00162.2009","volume":"297","author":"J Colmenero","year":"2009","unstructured":"Colmenero, J. et al. Effects of losartan on hepatic expression of non-phagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C. Am. J. Physiol. Gastrointest. Liver Physiol. 297, G726\u2013G734 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro201097_CR53","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/hep.23419","volume":"51","author":"M Moreno","year":"2009","unstructured":"Moreno, M. et al. Reduction of advanced liver fibrosis by short-term targeted delivery of an angiotensin receptor blocker to hepatic stellate cells in rats. Hepatology 51, 942\u2013952 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMoa0907929","volume":"362","author":"AJ Sanyal","year":"2010","unstructured":"Sanyal, A. J. et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N. Engl. J. Med. 362, 1\u20135 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro201097_CR55","doi-asserted-by":"crossref","first-page":"90A","DOI":"10.1016\/S0168-8278(09)60224-5","volume":"50","author":"A Sanyal","year":"2009","unstructured":"Sanyal, A. A randomized controlled trial of pioglitazone or vitamin E for nonalcoholic steatohepatitis (PIVENS) [abstract]. Hepatology 50, 90A (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR56","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/hep.22193","volume":"47","author":"RG Wells","year":"2008","unstructured":"Wells, R. G. The role of matrix stiffness in regulating cell behavior. Hepatology 47, 1394\u20131400 (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR57","doi-asserted-by":"crossref","first-page":"G1147","DOI":"10.1152\/ajpgi.00032.2007","volume":"293","author":"PC Georges","year":"2007","unstructured":"Georges, P. C. et al. Increased stiffness of the rat liver precedes matrix deposition: implications for fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 293, G1147\u2013G1154 (2007).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro201097_CR58","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1002\/hep.22813","volume":"49","author":"O Park","year":"2009","unstructured":"Park, O. et al. Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride. Hepatology 49, 1683\u20131694 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1189\/JLB.0309135","volume":"86","author":"B Gao","year":"2009","unstructured":"Gao, B., Radaeva, S. & Park, O. Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J. Leukoc. Biol. 86, 513\u2013528 (2009).","journal-title":"J. Leukoc. Biol."},{"key":"BFnrgastro201097_CR60","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clim.2008.08.008","volume":"130","author":"G Notas","year":"2009","unstructured":"Notas, G., Kisseleva, T. & Brenner, D. NK and NKT cells in liver injury and fibrosis. Clin. Immunol. 130, 16\u201326 (2009).","journal-title":"Clin. Immunol."},{"key":"BFnrgastro201097_CR61","first-page":"3213","volume":"119","author":"MK Connolly","year":"2009","unstructured":"Connolly, M. K. et al. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J. Clin. Invest. 119, 3213\u20133225 (2009).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201097_CR62","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","volume":"13","author":"E Seki","year":"2007","unstructured":"Seki, E. et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 13, 1324\u20131332 (2007).","journal-title":"Nat. Med."},{"key":"BFnrgastro201097_CR63","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/hep.22306","volume":"48","author":"E Seki","year":"2008","unstructured":"Seki, E. & Brenner, D. A. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48, 322\u2013335 (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR64","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/hep.22697","volume":"49","author":"J Guo","year":"2009","unstructured":"Guo, J. et al. Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. Hepatology 49, 960\u2013968 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR65","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/gut.2008.156307","volume":"58","author":"A Mencin","year":"2009","unstructured":"Mencin, A., Kluwe, J. & Schwabe, R. F. Toll-like receptors as targets in chronic liver diseases. Gut 58, 704\u2013720 (2009).","journal-title":"Gut"},{"key":"BFnrgastro201097_CR66","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jhep.2009.10.030","volume":"52","author":"JB Chakraborty","year":"2010","unstructured":"Chakraborty, J. B. & Mann, D. A. NF-kappaB signalling: embracing complexity to achieve translation. J. Hepatol. 52, 285\u2013291 (2010).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201097_CR67","doi-asserted-by":"crossref","first-page":"G1248","DOI":"10.1152\/ajpgi.90223.2008","volume":"296","author":"A Watanabe","year":"2009","unstructured":"Watanabe, A. et al. Inflammasome-mediated regulation of hepatic stellate cells. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G1248\u2013G1257 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro201097_CR68","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/hep.22413","volume":"48","author":"N Muhanna","year":"2008","unstructured":"Muhanna, N. et al. Activation of hepatic stellate cells after phagocytosis of lymphocytes: a novel pathway of fibrogenesis. Hepatology 48, 963\u2013977 (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR69","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2008.10.020","volume":"136","author":"AP Holt","year":"2009","unstructured":"Holt, A. P. et al. Liver myofibroblasts regulate infiltration and positioning of lymphocytes in human liver. Gastroenterology 136, 705\u2013714 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR70","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.addr.2009.03.011","volume":"61","author":"J Mann","year":"2009","unstructured":"Mann, J. & Mann, D. A. Transcriptional regulation of hepatic stellate cells. Adv. Drug Deliv. Rev. 61, 497\u2013512 (2009).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"BFnrgastro201097_CR71","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.cdd.4401979","volume":"14","author":"J Mann","year":"2007","unstructured":"Mann, J. et al. Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis. Cell Death Differ. 14, 275\u2013285 (2007).","journal-title":"Cell Death Differ."},{"key":"BFnrgastro201097_CR72","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2009.10.002","volume":"138","author":"J Mann","year":"2010","unstructured":"Mann, J. et al. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 138, 705\u2013714, 714 e1\u20134 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR73","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jmb.2007.06.006","volume":"371","author":"D Fritz","year":"2007","unstructured":"Fritz, D. & Stefanovic, B. RNA-binding protein RBMS3 is expressed in activated hepatic stellate cells and liver fibrosis and increases expression of transcription factor Prx1. J. Mol. Biol. 371, 585\u2013595 (2007).","journal-title":"J. Mol. Biol."},{"key":"BFnrgastro201097_CR74","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jhep.2008.11.025","volume":"50","author":"CJ Guo","year":"2009","unstructured":"Guo, C. J., Pan, Q., Li, D. G., Sun, H. & Liu, B. W. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis. J. Hepatol. 50, 766\u2013778 (2009).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201097_CR75","doi-asserted-by":"crossref","first-page":"G101","DOI":"10.1152\/ajpgi.00220.2009","volume":"298","author":"SK Venugopal","year":"2009","unstructured":"Venugopal, S. K. et al. Liver fibrosis causes down-regulation of miRNA-150 and miRNA-194 in hepatic stellate cells and their over-expression causes decreased stellate cell activation. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G101\u2013G106 (2009).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"BFnrgastro201097_CR76","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1053\/j.gastro.2009.02.081","volume":"136","author":"F Oakley","year":"2009","unstructured":"Oakley, F. et al. Angiotensin II activates I kappaB kinase phosphorylation of RelA at Ser 536 to promote myofibroblast survival and liver fibrosis. Gastroenterology 136, 2334\u20132344 e1 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR77","doi-asserted-by":"crossref","first-page":"e1372","DOI":"10.1371\/journal.pone.0001372","volume":"2","author":"M Buck","year":"2007","unstructured":"Buck, M. & Chojkier, M. A ribosomal S-6 kinase-mediated signal to C\/EBP-beta is critical for the development of liver fibrosis. PLoS ONE 2, e1372 (2007).","journal-title":"PLoS ONE"},{"key":"BFnrgastro201097_CR78","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/hep.20974","volume":"43","author":"SL Friedman","year":"2006","unstructured":"Friedman, S. L. & Bansal, M. B. Reversal of hepatic fibrosis\u2014fact or fantasy? Hepatology 43, S82\u2013S88 (2006).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR79","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7326\/0003-4819-149-6-200809160-00006","volume":"149","author":"V Mallet","year":"2008","unstructured":"Mallet, V. et al. Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C. Ann. Intern. Med. 149, 399\u2013403 (2008).","journal-title":"Ann. Intern. Med."},{"key":"BFnrgastro201097_CR80","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2893.2008.01052.x","volume":"16","author":"SA Gonzalez","year":"2009","unstructured":"Gonzalez, S. A. et al. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection. J. Viral Hepat. 16, 141\u2013148 (2009).","journal-title":"J. Viral Hepat."},{"key":"BFnrgastro201097_CR81","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2004.10.003","volume":"128","author":"F Oakley","year":"2005","unstructured":"Oakley, F. et al. Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis. Gastroenterology 128, 108\u2013120 (2005).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR82","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jhep.2009.03.024","volume":"51","author":"JX Jiang","year":"2009","unstructured":"Jiang, J. X., Mikami, K., Venugopal, S., Li, Y. & Torok, N. J. Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK\/STAT and Akt\/NF-kappaB-dependent pathways. J. Hepatol. 51, 139\u2013148 (2009).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201097_CR83","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2008.06.049","volume":"134","author":"V Krizhanovsky","year":"2008","unstructured":"Krizhanovsky, V. et al. Senescence of activated stellate cells limits liver fibrosis. Cell 134, 657\u2013667 (2008).","journal-title":"Cell"},{"key":"BFnrgastro201097_CR84","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","volume":"97","author":"A Regev","year":"2002","unstructured":"Regev, A. et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am. J. Gastroenterol. 97, 2614\u20132618 (2002).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro201097_CR85","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","volume":"128","author":"V Ratziu","year":"2005","unstructured":"Ratziu, V. et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128, 1898\u20131906 (2005).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR86","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/jhep.2003.09022","volume":"38","author":"P Bedossa","year":"2003","unstructured":"Bedossa, P., Dargere, D. & Paradis, V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38, 1449\u20131457 (2003).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR87","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/hep.23211","volume":"50","author":"ZD Goodman","year":"2009","unstructured":"Goodman, Z. D. et al. Fibrosis progression in chronic hepatitis C: morphometric image analysis in the HALT-C trial. Hepatology 50, 1738\u20131749 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR88","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/hep.22745","volume":"49","author":"V Calvaruso","year":"2009","unstructured":"Calvaruso, V. et al. Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient. Hepatology 49, 1236\u20131244 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR89","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/hep.23315","volume":"51","author":"JE Everhart","year":"2010","unstructured":"Everhart, J. E. et al. Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial. Hepatology 51, 585\u2013594 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR90","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2893.2009.01087.x","volume":"16","author":"L Castera","year":"2009","unstructured":"Castera, L. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. J. Viral Hepat. 16, 300\u2013314 (2009).","journal-title":"J. Viral Hepat."},{"key":"BFnrgastro201097_CR91","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/gut.2008.156489","volume":"58","author":"F Vizzutti","year":"2009","unstructured":"Vizzutti, F., Arena, U., Marra, F. & Pinzani, M. Elastography for the non-invasive assessment of liver disease: limitations and future developments. Gut 58, 157\u2013160 (2009).","journal-title":"Gut"},{"key":"BFnrgastro201097_CR92","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/ncpgasthep1025","volume":"5","author":"M Pinzani","year":"2008","unstructured":"Pinzani, M., Vizzutti, F., Arena, U. & Marra, F. Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography. Nat. Clin. Pract. Gastroenterol. Hepatol. 5, 95\u2013106 (2008).","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"BFnrgastro201097_CR93","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/hep.22007","volume":"47","author":"U Arena","year":"2008","unstructured":"Arena, U. et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 47, 380\u2013384 (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR94","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MEG.0b013e328332d2fa","volume":"22","author":"M Vigano","year":"2009","unstructured":"Vigano, M. et al. Transient elastography assessment of the liver stiffness dynamics during acute hepatitis B. Eur. J. Gastroenterol. Hepatol. 22, 180\u2013184 (2009).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro201097_CR95","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/hep.23240","volume":"51","author":"JA Carrion","year":"2010","unstructured":"Carrion, J. A. et al. Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation. Hepatology 51, 23\u201334 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR96","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hep.21972","volume":"47","author":"JA Talwalkar","year":"2008","unstructured":"Talwalkar, J. A. et al. Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications. Hepatology 47, 332\u2013342 (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR97","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jhep.2008.10.016","volume":"50","author":"S Bonekamp","year":"2009","unstructured":"Bonekamp, S., Kamel, I., Solga, S. & Clark, J. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J. Hepatol. 50, 17\u201335 (2009).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201097_CR98","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2214\/AJR.07.2086","volume":"189","author":"B Taouli","year":"2007","unstructured":"Taouli, B. et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am. J. Roentgenol. 189, 799\u2013806 (2007).","journal-title":"AJR Am. J. Roentgenol."},{"key":"BFnrgastro201097_CR99","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1148\/radiol.2463070077","volume":"246","author":"M Hagiwara","year":"2008","unstructured":"Hagiwara, M. et al. Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience. Radiology 246, 926\u2013934 (2008).","journal-title":"Radiology"},{"key":"BFnrgastro201097_CR100","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/hep.22394","volume":"48","author":"H Barash","year":"2008","unstructured":"Barash, H. et al. Functional magnetic resonance imaging monitoring of pathological changes in rodent livers during hyperoxia and hypercapnia. Hepatology 48, 1232\u20131241 (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR101","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ultrasmedbio.2005.05.004","volume":"31","author":"BJ Fahey","year":"2005","unstructured":"Fahey, B. J., Nightingale, K. R., Nelson, R. C., Palmeri, M. L. & Trahey, G. E. Acoustic radiation force impulse imaging of the abdomen: demonstration of feasibility and utility. Ultrasound Med. Biol. 31, 1185\u20131198 (2005).","journal-title":"Ultrasound Med. Biol."},{"key":"BFnrgastro201097_CR102","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1148\/radiol.2523081928","volume":"252","author":"M Friedrich-Rust","year":"2009","unstructured":"Friedrich-Rust, M. et al. Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography. Radiology 252, 595\u2013604 (2009).","journal-title":"Radiology"},{"key":"BFnrgastro201097_CR103","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2036.2009.04062.x","volume":"30","author":"JO Smith","year":"2009","unstructured":"Smith, J. O. & Sterling, R. K. Systematic review: Non-invasive methods of fibrosis analysis in chronic hepatitis C. Aliment. Pharmacol. Ther. 30, 557\u2013576 (2009).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201097_CR104","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1053\/j.gastro.2005.08.015","volume":"130","author":"MW Smith","year":"2006","unstructured":"Smith, M. W. et al. Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients. Gastroenterology 130, 179\u2013187 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR105","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jhep.2006.12.013","volume":"46","author":"V Leroy","year":"2007","unstructured":"Leroy, V. et al. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J. Hepatol. 46, 775\u2013782 (2007).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201097_CR106","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1582-4934.2007.00092.x","volume":"11","author":"OA Gressner","year":"2007","unstructured":"Gressner, O. A., Weiskirchen, R. & Gressner, A. M. Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality. J. Cell. Mol. Med. 11, 1031\u20131051 (2007).","journal-title":"J. Cell. Mol. Med."},{"issue":"6","key":"BFnrgastro201097_CR107","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/ajg.2009.746","volume":"105","author":"David Nunes","year":"2010","unstructured":"Nunes, D. et al. Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection. Am. J. Gastroenterol. doi: 10.1038\/ajg.2009.746.","journal-title":"American Journal of Gastroenterology"},{"key":"BFnrgastro201097_CR108","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1373\/clinchem.2006.070961","volume":"52","author":"Y Ngo","year":"2006","unstructured":"Ngo, Y. et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin. Chem. 52, 1887\u20131896 (2006).","journal-title":"Clin. Chem."},{"key":"BFnrgastro201097_CR109","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1002\/hep.22517","volume":"48","author":"MJ Mayo","year":"2008","unstructured":"Mayo, M. J. et al. Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay. Hepatology 48, 1549\u20131557 (2008).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR110","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/hep.22859","volume":"49","author":"G Sebastiani","year":"2009","unstructured":"Sebastiani, G. et al. SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C. Hepatology 49, 1821\u20131827 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR111","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","volume":"128","author":"L Castera","year":"2005","unstructured":"Castera, L. et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 128, 343\u2013350 (2005).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR112","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cgh.2008.10.034","volume":"7","author":"RJ Fontana","year":"2009","unstructured":"Fontana, R. J. et al. Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis. Clin. Gastroenterol. Hepatol. 7, 219\u2013226 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201097_CR113","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/j.gastro.2008.09.013","volume":"136","author":"V Nobili","year":"2009","unstructured":"Nobili, V. et al. Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology 136, 160\u2013167 (2009).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR114","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/01.qai.0000194238.15831.c7","volume":"41","author":"V de Ledinghen","year":"2006","unstructured":"de Ledinghen, V. et al. Diagnosis of hepatic fibrosis and cirrhosis by transient elastography in HIV\/hepatitis C virus-coinfected patients. J. Acquir. Immune Defic. Syndr. 41, 175\u2013179 (2006).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"BFnrgastro201097_CR115","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-2893.2009.01180.x","volume":"17","author":"M Sanchez-Conde","year":"2009","unstructured":"Sanchez-Conde, M. et al. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV\/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers. J. Viral Hepat. 17, 280\u2013286 (2009).","journal-title":"J. Viral Hepat."},{"key":"BFnrgastro201097_CR116","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.23020","volume":"50","author":"J Berenguer","year":"2009","unstructured":"Berenguer, J. et al. Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 50, 407\u2013413 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR117","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/lt.20432","volume":"11","author":"MW Russo","year":"2005","unstructured":"Russo, M. W. et al. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C. Liver Transpl. 11, 1235\u20131241 (2005).","journal-title":"Liver Transpl."},{"key":"BFnrgastro201097_CR118","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1046\/j.1365-2036.2002.01374.x","volume":"16","author":"A Armuzzi","year":"2002","unstructured":"Armuzzi, A. et al. Review article: breath testing for human liver function assessment. Aliment. Pharmacol. Ther. 16, 1977\u20131996 (2002).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201097_CR119","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1365-2036.2003.01752.x","volume":"18","author":"A Petrolati","year":"2003","unstructured":"Petrolati, A. et al. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment. Pharmacol. Ther. 18, 785\u2013790 (2003).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro201097_CR120","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","volume":"133","author":"C Ripoll","year":"2007","unstructured":"Ripoll, C. et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology 133, 481\u2013488 (2007).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR121","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrgastro.2009.197","volume":"7","author":"JA Talwalkar","year":"2010","unstructured":"Talwalkar, J. A. Antifibrotic therapies\u2014emerging biomarkers as treatment end points. Nat. Rev. Gastroenterol. Hepatol. 7, 59\u201361 (2010).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro201097_CR122","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1755-1536-2-6","volume":"2","author":"GL Hold","year":"2009","unstructured":"Hold, G. L., Untiveros, P., Saunders, K. A. & El-Omar, E. M. Role of host genetics in fibrosis. Fibrogenesis Tissue Repair 2, 6 (2009).","journal-title":"Fibrogenesis Tissue Repair"},{"key":"BFnrgastro201097_CR123","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cld.2008.07.012","volume":"12","author":"S Weber","year":"2008","unstructured":"Weber, S., Gressner, O. A., Hall, R., Grunhage, F. & Lammert, F. Genetic determinants in hepatic fibrosis: from experimental models to fibrogenic gene signatures in humans. Clin. Liver Dis. 12, 747\u2013757 (2008).","journal-title":"Clin. Liver Dis."},{"key":"BFnrgastro201097_CR124","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/hep.22707","volume":"49","author":"HE Wasmuth","year":"2009","unstructured":"Wasmuth, H. E. et al. The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB. Hepatology 49, 775\u2013780 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1055\/s-2006-960168","volume":"27","author":"T Asselah","year":"2007","unstructured":"Asselah, T. et al. Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C. Semin. Liver Dis. 27, 13\u201327 (2007).","journal-title":"Semin. Liver Dis."},{"key":"BFnrgastro201097_CR126","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.21695","volume":"46","author":"H Huang","year":"2007","unstructured":"Huang, H. et al. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology 46, 297\u2013306 (2007).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR127","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2006.02.032","volume":"130","author":"H Huang","year":"2006","unstructured":"Huang, H. et al. Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology 130, 1679\u20131687 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR128","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/hep.23111","volume":"50","author":"M Marcolongo","year":"2009","unstructured":"Marcolongo, M. et al. A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C. Hepatology 50, 1038\u20131044 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR129","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00109-003-0505-0","volume":"82","author":"HE Wasmuth","year":"2004","unstructured":"Wasmuth, H. E. et al. CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia. J. Mol. Med. 82, 64\u201369 (2004).","journal-title":"J. Mol. Med."},{"key":"BFnrgastro201097_CR130","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ng1599","volume":"37","author":"S Hillebrandt","year":"2005","unstructured":"Hillebrandt, S. et al. Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nat. Genet. 37, 835\u2013843 (2005).","journal-title":"Nat. Genet."},{"key":"BFnrgastro201097_CR131","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1002\/hep.23137","volume":"50","author":"TM Hung","year":"2009","unstructured":"Hung, T. M. et al. A novel nonsynonymous variant of matrix metalloproteinase-7 confers risk of liver cirrhosis. Hepatology 50, 1184\u20131193 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR132","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/hep.23162","volume":"50","author":"ND Freedman","year":"2009","unstructured":"Freedman, N. D. et al. Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology 50, 1360\u20131369 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR133","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1053\/j.gastro.2005.08.056","volume":"129","author":"CE Ruhl","year":"2005","unstructured":"Ruhl, C. E. & Everhart, J. E. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 129, 1928\u20131936 (2005).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR134","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hep.23279","volume":"51","author":"AA Modi","year":"2010","unstructured":"Modi, A. A. et al. Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 51, 201\u2013209 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR135","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/sj.bjp.0706812","volume":"148","author":"ES Chan","year":"2006","unstructured":"Chan, E. S. et al. Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis. Br. J. Pharmacol. 148, 1144\u20131155 (2006).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrgastro201097_CR136","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.cgh.2009.08.004","volume":"7","author":"HL Chan","year":"2009","unstructured":"Chan, H. L. et al. Hepatitis B virus genotype C is associated with more severe liver fibrosis than genotype B. Clin. Gastroenterol. Hepatol. 7, 1361\u20131366 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro201097_CR137","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jhep.2009.05.016","volume":"51","author":"PY Bochud","year":"2009","unstructured":"Bochud, P. Y. et al. Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. J. Hepatol. 51, 655\u2013666 (2009).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201097_CR138","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.23136","volume":"50","author":"J Macias","year":"2009","unstructured":"Macias, J. et al. Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus\/hepatitis C virus. Hepatology 50, 1056\u20131063 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR139","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cld.2008.07.006","volume":"12","author":"M Pinzani","year":"2008","unstructured":"Pinzani, M. & Vizzutti, F. Fibrosis and cirrhosis reversibility: clinical features and implications. Clin. Liver Dis. 12, 901\u2013913 (2008).","journal-title":"Clin. Liver Dis."},{"key":"BFnrgastro201097_CR140","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1665-2681(19)31740-5","volume":"8","author":"P Ramachandran","year":"2009","unstructured":"Ramachandran, P. & Iredale, J. P. Reversibility of liver fibrosis. Ann. Hepatol. 8, 283\u2013291 (2009).","journal-title":"Ann. Hepatol."},{"key":"BFnrgastro201097_CR141","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/hep.23478","volume":"51","author":"G Garcia-Tsao","year":"2010","unstructured":"Garcia-Tsao, G., Friedman, S., Iredale, J. & Pinzani, M. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology 51, 1445\u20131449 (2010).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR142","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.gastro.2009.09.007","volume":"138","author":"MG Ghany","year":"2010","unstructured":"Ghany, M. G. et al. Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C. Gastroenterology 138, 136\u2013146 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro201097_CR143","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2006.04.006","volume":"45","author":"F Kazemi","year":"2006","unstructured":"Kazemi, F. et al. Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices. J. Hepatol. 45, 230\u2013235 (2006).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201097_CR144","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/MCG.0b013e318050074f","volume":"42","author":"R Masuzaki","year":"2008","unstructured":"Masuzaki, R. et al. Risk assessment of hepatocellular carcinoma in chronic hepatitis C patients by transient elastography. J. Clin. Gastroenterol. 42, 839\u2013843 (2008).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrgastro201097_CR145","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jhep.2005.07.036","volume":"44","author":"S Nagula","year":"2006","unstructured":"Nagula, S., Jain, D., Groszmann, R. J. & Garcia-Tsao, G. Histological\u2013hemodynamic correlation in cirrhosis\u2014a histological classification of the severity of cirrhosis. J. Hepatol. 44, 111\u2013117 (2006).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201097_CR146","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI30542","volume":"117","author":"JP Iredale","year":"2007","unstructured":"Iredale, J. P. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J. Clin. Invest. 117, 539\u2013548 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnrgastro201097_CR147","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","volume":"43","author":"Y Popov","year":"2005","unstructured":"Popov, Y., Patsenker, E., Fickert, P., Trauner, M. & Schuppan, D. Mdr2 (Abcb4)\u2212\/\u2212 mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J. Hepatol. 43, 1045\u20131054 (2005).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201097_CR148","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1076-6332(05)80410-6","volume":"2","author":"SN Lichtman","year":"1995","unstructured":"Lichtman, S. N., Wang, J. & Clark, R. L. A microcholangiographic study of liver disease models in rats. Acad. Radiol. 2, 515\u2013521 (1995).","journal-title":"Acad. Radiol."},{"key":"BFnrgastro201097_CR149","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2007.11.021","volume":"48","author":"Y Popov","year":"2008","unstructured":"Popov, Y. et al. Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies. J. Hepatol. 48, 453\u2013464 (2008).","journal-title":"J. Hepatol."},{"key":"BFnrgastro201097_CR150","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/ncpgasthep0813","volume":"4","author":"SL Friedman","year":"2007","unstructured":"Friedman, S. L. Reversibility of hepatic fibrosis and cirrhosis--is it all hype? Nat. Clin. Pract. Gastroenterol. Hepatol. 4, 236\u2013237 (2007).","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"BFnrgastro201097_CR151","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1586\/17474124.2.6.803","volume":"2","author":"Z Ghiassi-Nejad","year":"2008","unstructured":"Ghiassi-Nejad, Z. & Friedman, S. L. Advances in antifibrotic therapy. Expert Rev. Gastroenterol. Hepatol. 2, 803\u2013816 (2008).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"BFnrgastro201097_CR152","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.cld.2008.07.011","volume":"12","author":"DC Rockey","year":"2008","unstructured":"Rockey, D. C. Current and future anti-fibrotic therapies for chronic liver disease. Clin. Liver Dis. 12, 939\u2013962 (2008).","journal-title":"Clin. Liver Dis."},{"key":"BFnrgastro201097_CR153","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/hep.23123","volume":"50","author":"Y Popov","year":"2009","unstructured":"Popov, Y. & Schuppan, D. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 50, 1294\u20131306 (2009).","journal-title":"Hepatology"},{"key":"BFnrgastro201097_CR154","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1021\/mp700118p","volume":"5","author":"MH Schoemaker","year":"2008","unstructured":"Schoemaker, M. H. et al. PDGF-receptor beta-targeted adenovirus redirects gene transfer from hepatocytes to activated stellate cells. Mol. Pharm. 5, 399\u2013406 (2008).","journal-title":"Mol. Pharm."},{"key":"BFnrgastro201097_CR155","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1124\/jpet.106.114496","volume":"321","author":"T Gonzalo","year":"2007","unstructured":"Gonzalo, T. et al. Local inhibition of liver fibrosis by specific delivery of a PDGF kinase inhibitor to hepatic stellate cells. J. Pharmacol. Exp. Ther. 321, 856\u2013865 (2007).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrgastro201097_CR156","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nbt0408-399","volume":"26","author":"SL Friedman","year":"2008","unstructured":"Friedman, S. L. Targeting siRNA to arrest fibrosis. Nat. Biotechnol. 26, 399\u2013400 (2008).","journal-title":"Nat. Biotechnol."},{"key":"BFnrgastro201097_CR157","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nbt1396","volume":"26","author":"Y Sato","year":"2008","unstructured":"Sato, Y. et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat. Biotechnol. 26, 431\u2013442 (2008).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2010.97","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2010.97.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2010.97.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T04:21:44Z","timestamp":1740198104000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2010.97"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,29]]},"references-count":157,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["BFnrgastro201097"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2010.97","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718674607.793516938","asserted-by":"object"}]},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,29]]}}}